Re: [MLUG - DISCUSSION] [POLITICS] how did you like your 25% pay cut?

[Mike Miller <EMAIL:PROTECTED>]

I mean to add this part to what I sent earlier (recapped below).

   There are several reasons for the disparity. The Canadian system takes
   advantage of centralized buying by the provincial governments that have
   more market heft and buy in bulk, lowering prices. By contrast, the
   U.S. has explicit laws that prohibit Medicare or Medicaid from
   negotiating drug prices. In addition, price negotiations by Canadian
   health insurers are based on evaluations of the clinical effectiveness
   of prescription drugs [13], allowing the relative prices of
   therapeutically-similar drugs to be considered in context. The Canadian
   Patented Medicine Prices Review Board also has the authority to set a
   fair and reasonable price on patented products, either comparing it to
   similar drugs already on the market, or by taking the average price in
   seven developed nations. [60][61] Prices are also lowered through more
   limited patent protection in Canada. In the U.S., a drug patent may be
   extended five years to make up for time lost in development.[62] Some
   generic drugs are thus available on Canadian shelves sooner.[63]

6. ^ a b [1]Open Medicine, Vol 1, No 1 (2007), Research: A systematic 
review of studies comparing health outcomes in Canada and the United 
States, Gordon H. Guyatt, et al.
http://www.openmedicine.ca/article/view/8/1
7. ^ Health system attainment and performance in all Member States, 
ranked by eight measures, estimates for 1997
http://www.who.int/whr/2000/en/annex01_en.pdf
8. ^ Long-term mortality of patients with acute myocardial infarction in 
the United States and Canada: comparison of patients enrolled in Global 
Utilization of Streptokinase and t-PA for Occluded Coronary Arteries 
(GUSTO)-I. Kaul P, et al., Circulation. 2004 Sep 28;110(13):1754-60. 
PMID15381645
http://circ.ahajournals.org/cgi/content/full/110/13/1754
13. http://dsp-psd.communication.gc.ca/Collection-R/LoPBdP/BP/bp300-e.htm
60. ^ [6]
61. ^ [7]
62. ^ [8]
63. ^ Skinner, Brett J. (2006). Price Controls, Patents, and Cross-Border 
Internet Pharmacies (PDF). Critical Issues Bulletin page 6. Fraser 
Institute. Retrieved on 2007-07-12. ."Nearly half the value of sales (47%) 
in generic products sold through cross-border Internet pharmacies was 
accounted for by drugs that were not yet genericized in the United States. 
Most of these drugs were likely still under active patent protection in 
the United States..

Mike


On Sun, 30 Sep 2007, Mike Miller wrote:

> That's not it.  It's because the Canadian government regulates drug prices:
>
> http://en.wikipedia.org/wiki/Canadian_and_American_health_care_systems_compared
>
>   One of the most important differences between the two countries is the
>   much higher cost of drugs in the United States. In the U.S., $728 per
>   capita is spent each year on drugs, while in Canada it is $509.[55] At
>   the same time, consumption is higher in Canada, with about 12
>   prescriptions being filled per person each year in Canada and 10.6 in
>   the United States.[57] The main difference is that patented drug prices
>   in Canada average between 35% and 45% lower than in the United
>   States.[58] The price differential for brand-name drugs between the two
>   countries has led Americans to purchase upward of US$1 billion in drugs
>   per year from Canadian pharmacies.[59]
>
> 55. ^ a b Valrie Paris and Elizabeth Docteur. Pharmaceutical Pricing
>  and Reimbursement Policies in Canada OECD Health Working Papers
>  http://www.oecd.org/dataoecd/21/40/37868186.pdf
> 56. ^ "Taking The Pulse Of Health Care Systems: Experiences Of Patients With
>  Health Problems In Six Countries" Cathy Schoen, Health Affairs. Chevy
>  Chase: Jul-Dec 2005. Vol. 24 pg. 509, 17 pgs
> 57. ^ Val	rie Paris and Elizabeth Docteur. Pharmaceutical Pricing and
>  Reimbursement Policies in Canada OECD Health Working Papers pg. 49
>  http://www.oecd.org/dataoecd/21/40/37868186.pdf
> 58. ^ Val	rie Paris and Elizabeth Docteur. Pharmaceutical Pricing and
>  Reimbursement Policies in Canada OECD Health Working Papers pg. 52
>  http://www.oecd.org/dataoecd/21/40/37868186.pdf
> 59. ^ (2004-03-16) "Internet pharmacy: prices on the up-and-up". CMAJ 170
>  (6): 945-946. DOI:10.1503/cmaj.104001. PMID 15023915. Retrieved on
>  2007-07-11.
>  http://www.cmaj.ca/cgi/content/full/170/6/945?etoc

_______________________________________________
discussion mailing list
EMAIL:PROTECTED
http://mlug.missouri.edu/mailman/listinfo/discussion